Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
News 30 Oct 2023 MSF uses 1999 Nobel Peace Prize to help found pioneering not-for-profit drug development organization
News 6 Oct 2023 DNDi 2023 Projects of the Year recognize contributions of DNDi teams and partners working to deliver medical innovations for people affected by Chagas disease and mycetoma
News 14 Sep 2023 DNDi’s Centres of Excellence: Towards the sustainable elimination of visceral leishmaniasis in India
News 29 Aug 2023 DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa
News 7 Jul 2023 Germany’s Federal Ministry of Education and Research (BMBF) grants funding to advance the fight against poverty-related and neglected tropical diseases
News 1 Jun 2023 Statement from Dr Luis Pizarro, Executive Director of DNDi, about the Princess of Asturias Award for International Cooperation
